In: European Journal of Medical Research, 24 (2019), Nr. 14. pp. 1-8. ISSN 2047-783X
Preview |
PDF, English
- main document
Download (908kB) | Lizenz: ![]() |
Abstract
Purpose: Cognitive impairment and reduced quality of life is a common condition in patients with heart failure (HF). Percutaneous mitral valve repair using (PMVR) MitraClip (MC) has emerged as a promising interventional tool, reducing all-cause mortality and hospitalization as well as increasing cognitive functioning and quality of life. However, the benefit of HF patients with severely depressed cognitive functioning remains unknown.
Methods: We assessed cognitive functioning (figural memory—FGT, executive function—TOL, TMT B), psychosocial functioning (depression—PHQ-9, quality of life—SF36), and clinical parameters (echocardiography, 6-min walk test distance, and cardiac biomarkers) 1 day before (t0) and 6 weeks after (t1) MC intervention in HF patients (n = 40). First, paired sample t tests were conducted to uncover improvements in cognitive functioning post-MC intervention. Second, the COGBAT Norm-sample, a representative age-matched healthy sample, was used to compare participants’ individual scores. Third, bivariate linear regressions were calculated for all key predictors of the detected improvements in cognitive functioning post-MC intervention (t1–t0).
Results: Following the MC intervention, we found significant improvements in figural memory, executive functioning, and psychosocial functioning. Most of the patients with depressed executive functioning before the MC intervention showed post-intervention test scores within the normal range (> 50th percentile; t0 22.5% vs. t1 60%) as compared to the normative COGBAT sample. Regression analyses revealed that lower baseline scores in planning ability before the MC intervention (t0) were associated with greater planning ability (TOL; B = − 0.78, 95% CI − 1.04 to − 0.53), figural memory (FGT; B = − 0.26, 95% CI − 0.44 to − 0.07), and cognitive flexibility (TMT B; B = − 0.36, 95% CI − 0.50 to − 0.23) improvement post-MC intervention (t1–t0). Psychosocial functioning and age were not associated with these improvements.
Conclusions: Patients with depressed executive functioning showed the greatest benefit from the MC intervention regarding cognitive functioning. Age and psychological functioning seem less important for cognitive performance improvements post-MC intervention. Hence, severely depressed cognitive functioning in patients is not a contraindication for PMVR using MitraClip.
Document type: | Article |
---|---|
Journal or Publication Title: | European Journal of Medical Research |
Volume: | 24 |
Number: | 14 |
Publisher: | BioMed Central |
Place of Publication: | London |
Date Deposited: | 29 Apr 2019 07:53 |
Date: | 2019 |
ISSN: | 2047-783X |
Page Range: | pp. 1-8 |
Faculties / Institutes: | Medizinische Fakultät Heidelberg > Medizinische Universitäts-Klinik und Poliklinik Medizinische Fakultät Heidelberg > Psychiatrische Universitätsklinik Medizinische Fakultät Heidelberg > Psychosomatische Universitätsklinik |
DDC-classification: | 150 Psychology 610 Medical sciences Medicine |
Uncontrolled Keywords: | Chronic heart failure, MitraClip intervention, Cognitive performance, Memory, Executive function, Depression, Quality of life |